![Jason Hoitt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 336 231 $ in data 30/06/2026
Jason Hoitt currently works at Stoke Therapeutics, Inc., as Chief Patient Officer from 2025.
Mr. Hoitt also formerly worked at Sarepta Therapeutics, Inc., as Head-US Sales from 2013 to 2017, Insmed, Inc., as Vice President & Head-US Sales, Dova Pharmaceuticals, Inc., as Chief Commercial Officer from 2018 to 2019, and Provention Bio, Inc., as Chief Commercial Officer from 2020 to 2023.
Mr. Hoitt received his undergraduate degree in 1999 from College of the Holy Cross (Massachusetts).
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 10.276 ( 0,02% ) | 336 231 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Corporate Officer/Principal | 15/04/2024 |
| Società | Posizione | Fine |
|---|---|---|
| PROVENTION BIO, INC. | Corporate Officer/Principal | 01/06/2023 |
| DOVA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 12/11/2019 |
| INSMED INCORPORATED | Vendite & Marketing | - |
| SAREPTA THERAPEUTICS, INC. | Vendite & Marketing | 01/05/2017 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
